- Home
- / Sejong Medical
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Sejong Medical financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Stock Price
₩412
2024-10-29
Market Capitalization
₩23 B
2024-07-23
Revenue
₩19 B
FY, 2024
CreditSafe Score
?
Score changed on Jun 14, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| KRW | FY, 2018 | FY, 2019 | FY, 2020 | FY, 2021 | FY, 2022 | FY, 2023 | FY, 2024 |
|---|---|---|---|---|---|---|---|
| Revenue | 14.8B | 16.2B | 15.1B | 18.0B | 16.1B | 18.0B | 19.0B |
| Cost of goods sold | 2.9B | 2.7B | 3.2B | 6.3B | 4.0B | 7.7B | 9.7B |
| Gross profit | 12.9B | 13.9B | 12.8B | 12.7B | 13.6B | 26.0B | 10.8B |
| Gross profit margin, % | 85.4% | 84.9% | 70.2% | 84.3% | 144.4% | 56.9% | |
| Operating expense total | 7.8B | 8.4B | 10.5B | 13.2B | 12.5B | 9.0B | 8.3B |
| Depreciation and amortization | 941.6M | 1.9B | 1.8B | 1.1B | 1.4B | 1.7B | 1.4B |
| EBITDA | 5.1B | 5.4B | 2.3B | (506.4M) | (15.6B) | 16.9B | (12.4B) |
| EBITDA margin, % | 33.4% | 15.0% | -2.8% | -96.8% | 94.1% | -65.4% | |
| EBIT | 4.0B | 3.4B | (704.1M) | (3.1B) | (74.4B) | (18.1B) | (60.2B) |
| EBIT margin, % | 20.8% | -4.7% | -17.2% | -462.7% | -100.4% | -317.7% | |
| Interest income | 208.6M | 253.9M | 287.4M | 297.5M | 726.8M | 298.2M | 277.2M |
| Interest expense | 60.2M | 82.3M | 207.8M | 597.5M | 4.7B | 11.4B | 5.5B |
| Pre tax profit | 4.4B | 3.7B | (114.7M) | (5.2B) | (91.3B) | (25.4B) | (71.0B) |
| Income tax expense | 759.7M | 641.1M | (569.6M) | 725.7M | 219.2M | (2.3B) | 1.1B |
| Net Income | 3.6B | 3.1B | 454.9M | (5.9B) | (91.5B) | (23.1B) | (72.1B) |